Release 5 Draft Ballot

This is the Continuous Integration Build of FHIR (will be incorrect/inconsistent at times).
See the Directory of published versions Value Set

Public Health and Emergency Response Work Group Maturity Level: 1Draft Use Context: Not Intended for Production use

This is a value set defined by the FHIR project.


Defining URL:
Title:Vaccine Administered Value Set

This identifies the vaccine substance administered - CVX codes.

Committee:Public Health and Emergency Response Work Group
OID:2.16.840.1.113883. (for OID based terminology systems)
Source ResourceXML / JSON

This value set is used in the following places:

This value set includes codes based on the following rules:


This expansion generated 10 Aug 2022

This value set contains 287 concepts

Expansion based on version 20210406

CodeSystemDisplayEnglish (English, en)
  54 vaccine, type 4, live, oraladenovirus, type 4
  55 vaccine, type 7, live, oraladenovirus, type 7
  82 vaccine, unspecified formulationadenovirus, unspecified formulation
  24 vaccineanthrax
  19 Calmette-Guerin vaccineBCG
  27 antitoxin
  26 vaccine, unspecified formulationcholera, unspecified formulation
  29 immune globulin, intravenousCMVIG
  56 fever vaccinedengue fever
  12 antitoxin
  28 and tetanus toxoids, adsorbed for pediatric useDT (pediatric)
  20, tetanus toxoids and acellular pertussis vaccineDTaP
  106, tetanus toxoids and acellular pertussis vaccine, 5 pertussis antigensDTaP, 5 pertussis antigens
  107, tetanus toxoids and acellular pertussis vaccine, unspecified formulationDTaP, unspecified formulation
  110 B and poliovirus vaccineDTaP-Hep B-IPV
  50 influenzae type b conjugate vaccineDTaP-Hib
  120, tetanus toxoids and acellular pertussis vaccine, Haemophilus influenzae type b conjugate, and poliovirus vaccine, inactivated (DTaP-Hib-IPV)DTaP-Hib-IPV
  130, tetanus toxoids and acellular pertussis vaccine, and poliovirus vaccine, inactivatedDTaP-IPV
  01, tetanus toxoids and pertussis vaccineDTP
  22 influenzae type b conjugate vaccineDTP-Hib
  102 Haemophilus influenzae type b conjugate and hepatitis b vaccineDTP-Hib-Hep B
  57 vaccinehantavirus
  52 A vaccine, adult dosageHep A, adult
  83 A vaccine, pediatric/adolescent dosage, 2 dose scheduleHep A, ped/adol, 2 dose
  84 A vaccine, pediatric/adolescent dosage, 3 dose scheduleHep A, ped/adol, 3 dose
  31 A vaccine, pediatric dosage, unspecified formulationHep A, pediatric, unspecified formulation
  85 A vaccine, unspecified formulationHep A, unspecified formulation
  104 A and hepatitis B vaccineHep A-Hep B
  30 B immune globulinHBIG
  08 B vaccine, pediatric or pediatric/adolescent dosageHep B, adolescent or pediatric
  42 B vaccine, adolescent/high risk infant dosageHep B, adolescent/high risk infant
  43 B vaccine, adult dosageHep B, adult
  44 B vaccine, dialysis patient dosageHep B, dialysis
  45 B vaccine, unspecified formulationHep B, unspecified formulation
  58 C vaccineHep C
  59 E vaccineHep E
  60 simplex virus, type 2 vaccineherpes simplex 2
  46 influenzae type b vaccine, PRP-D conjugateHib (PRP-D)
  47 influenzae type b vaccine, HbOC conjugateHib (HbOC)
  48 influenzae type b vaccine, PRP-T conjugateHib (PRP-T)
  49 influenzae type b vaccine, PRP-OMP conjugateHib (PRP-OMP)
  17 influenzae type b vaccine, conjugate unspecified formulationHib, unspecified formulation
  51 influenzae type b conjugate and Hepatitis B vaccineHib-Hep B
  61 immunodeficiency virus vaccineHIV
  118 papilloma virus vaccine, bivalentHPV, bivalent
  62 papilloma virus vaccine, quadrivalentHPV, quadrivalent
  86 globulin, intramuscularIG
  87 globulin, intravenousIGIV
  14 globulin, unspecified formulationIG, unspecified formulation
  111 virus vaccine, live, attenuated, for intranasal useinfluenza, live, intranasal
  15 virus vaccine, split virus (incl. purified surface antigen)-retired CODEinfluenza, split (incl. purified surface antigen)
  16 virus vaccine, whole virusinfluenza, whole
  88 virus vaccine, unspecified formulationinfluenza, unspecified formulation
  123 virus vaccine, H5N1, A/Vietnam/1203/2004 (national stockpile)influenza, H5N1-1203
  10 vaccine, inactivatedIPV
  02 poliovirus vaccine, live, oralOPV
  89 vaccine, unspecified formulationpolio, unspecified formulation
  39 Encephalitis Vaccine SCJapanese encephalitis SC
  63 virus vaccineJunin virus
  64 vaccineleishmaniasis
  65 vaccineleprosy
  66 disease vaccineLyme disease
  03, mumps and rubella virus vaccineMMR
  04 and rubella virus vaccineM/R
  94, mumps, rubella, and varicella virus vaccineMMRV
  67 vaccinemalaria
  05 virus vaccinemeasles
  68 vaccinemelanoma
  32 polysaccharide vaccine (MPSV4)meningococcal MPSV4
  103 C conjugate vaccinemeningococcal C conjugate
  114 polysaccharide (groups A, C, Y and W-135) diphtheria toxoid conjugate vaccine (MCV4P)meningococcal MCV4P
  108 ACWY vaccine, unspecified formulationmeningococcal ACWY, unspecified formulation
  07 virus vaccinemumps
  69 virus vaccineparainfluenza-3
  11 vaccinepertussis
  23 vaccineplague
  33 polysaccharide vaccine, 23 valentpneumococcal polysaccharide PPV23
  100 conjugate vaccine, 7 valentpneumococcal conjugate PCV 7
  109 vaccine, unspecified formulationpneumococcal, unspecified formulation
  70 fever vaccineQ fever
  18 vaccine, for intramuscular injection RETIRED CODErabies, intramuscular injection
  40 vaccine, for intradermal injectionrabies, intradermal injection
  90 vaccine, unspecified formulationrabies, unspecified formulation
  72 fever vaccinerheumatic fever
  73 Valley fever vaccineRift Valley fever
  34 immune globulinRIG
  119, live, monovalent vaccinerotavirus, monovalent
  122 vaccine, unspecified formulationrotavirus, unspecified formulation
  116, live, pentavalent vaccinerotavirus, pentavalent
  74, live, tetravalent vaccinerotavirus, tetravalent
  71 syncytial virus immune globulin, intravenousRSV-IGIV
  93 syncytial virus monoclonal antibody (palivizumab), intramuscularRSV-MAb
  06 virus vaccinerubella
  38 and mumps virus vaccinerubella/mumps
  76 bacteriophage lysateStaphylococcus bacterio lysate
  113 and diphtheria toxoids, adsorbed, preservative free, for adult use (5 Lf of tetanus toxoid and 2 Lf of diphtheria toxoid)Td (adult), 5 Lf tetanus toxoid, preservative free, adsorbed
  09 and diphtheria toxoids, adsorbed, preservative free, for adult use (2 Lf of tetanus toxoid and 2 Lf of diphtheria toxoid)Td (adult), 2 Lf tetanus toxoid, preservative free, adsorbed
  115 toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine, adsorbedTdap
  35 toxoid, adsorbed
  112 toxoid, unspecified formulation
  77 encephalitis vaccinetick-borne encephalitis
  13 immune globulinTIG
  95 skin test; old tuberculin, multipuncture deviceTST-OT tine test
  96 skin test; purified protein derivative solution, intradermalTST-PPD intradermal
  97 skin test; purified protein derivative, multipuncture deviceTST-PPD tine test
  98 skin test; unspecified formulationTST, unspecified formulation
  78 vaccine
  91 vaccine, unspecified formulationtyphoid, unspecified formulation
  25 vaccine, live, oraltyphoid, oral
  41 vaccine, parenteral, other than acetone-killed, driedtyphoid, parenteral
  53 vaccine, parenteral, acetone-killed, dried (U.S. military)typhoid, parenteral, AKD (U.S. military)
  101 Vi capsular polysaccharide vaccinetyphoid, ViCPs
  75 (smallpox) vaccinevaccinia (smallpox)
  105 (smallpox) vaccine, dilutedvaccinia (smallpox) diluted
  79 immune globulin
  21 virus vaccinevaricella
  81 equine encephalitis, inactivatedVEE, inactivated
  80 equine encephalitis, live, attenuatedVEE, live
  92 equine encephalitis vaccine, unspecified formulationVEE, unspecified formulation
  36 zoster immune globulinVZIG
  117 zoster immune globulin (Investigational New Drug)VZIG (IND)
  37 fever vaccineyellow fever
  121 vaccine, livezoster live
  998 vaccine administered
  999 vaccine or immune globulinunknown
  99 - do not use
  133 conjugate vaccine, 13 valentPneumococcal conjugate PCV 13
  134 Encephalitis vaccine for intramuscular administrationJapanese Encephalitis IM
  137, unspecified formulation
  136 oligosaccharide (groups A, C, Y and W-135) diphtheria toxoid conjugate vaccine (MCV4O)Meningococcal MCV4O
  135, high dose seasonal, preservative-freeInfluenza, high dose seasonal
  131 record of a typhus vaccinationtyphus, historical
  132 diphtheria and tetanus toxoids and acellular pertussis, poliovirus, Haemophilus b conjugate and hepatitis B (recombinant) vaccine.DTaP-IPV-HIB-HEP B, historical
  128 influenza-H1N1-09, all formulationsNovel Influenza-H1N1-09, all formulations
  125 Influenza-H1N1-09, live virus for nasal administrationNovel Influenza-H1N1-09, nasal
  126 influenza-H1N1-09, preservative-free, injectableNovel influenza-H1N1-09, preservative-free
  127 influenza-H1N1-09, injectableNovel influenza-H1N1-09
  138 and diphtheria toxoids, not adsorbed, for adult useTd (adult)
  139 unspecified formulation
  140, seasonal, injectable, preservative free
  129 Encephalitis vaccine, unspecified formulationJapanese Encephalitis, unspecified formulation
  141, seasonal, injectable
  142 toxoid, not adsorbed
  143, type 4 and type 7, live, oralAdenovirus types 4 and 7
  144 influenza, intradermal, preservative freeinfluenza, seasonal, intradermal, preservative free
  145 syncytial virus monoclonal antibody (motavizumab), intramuscularRSV-MAb (new)
  146 and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus, Haemophilus b Conjugate (Meningococcal Protein Conjugate), and Hepatitis B (Recombinant) Vaccine.DTaP,IPV,Hib,HepB
  147, MCV4, unspecified conjugate formulation(groups A, C, Y and W-135)meningococcal MCV4, unspecified formulation
  148 Groups C and Y and Haemophilus b Tetanus Toxoid Conjugate VaccineMeningococcal C/Y-HIB PRP
  149, live, intranasal, quadrivalent
  150, injectable, quadrivalent, preservative freeinfluenza, injectable, quadrivalent, preservative free
  151 nasal, unspecified formulation
  152 Conjugate, unspecified formulation
  153, injectable, Madin Darby Canine Kidney, preservative freeInfluenza, injectable, MDCK, preservative free
  154 A immune globulinHep A, IG
  155, trivalent, recombinant, injectable influenza vaccine, preservative freeinfluenza, recombinant, injectable, preservative free
  156 Immune globulin- IV or IMRho(D)-IG
  157 Immune globulin - IMRho(D) -IG IM
  158, injectable, quadrivalent, contains preservativeinfluenza, injectable, quadrivalent
  159 Unspecified formulationRho(D) - Unspecified formulation
  160 A monovalent (H5N1), adjuvanted, National stockpile 2013Influenza A monovalent (H5N1), ADJUVANTED-2013
  801 Adjuvant
  161, injectable,quadrivalent, preservative free, pediatric
  162 B vaccine, fully recombinantmeningococcal B, recombinant
  163 B vaccine, recombinant, OMV, adjuvantedmeningococcal B, OMV
  164 B, unspecified formulationmeningococcal B, unspecified
  165 Papillomavirus 9-valent vaccineHPV9
  166, intradermal, quadrivalent, preservative free, injectableinfluenza, intradermal, quadrivalent, preservative free
  167 vaccine of unknown formulation and unknown serogroupsmeningococcal, unknown serogroups
  168 trivalent influenza vaccine, adjuvanted, preservative freeinfluenza, trivalent, adjuvanted
  169 A, live attenuated-IMHep A, live attenuated
  170 diphtheria, tetanus toxoids and acellular pertussis vaccine, Haemophilus influenzae type b conjugate, and poliovirus vaccine, inactivated (DTaP-Hib-IPV)DTAP/IPV/HIB - non-US
  171, injectable, Madin Darby Canine Kidney, preservative free, quadrivalentInfluenza, injectable, MDCK, preservative free, quadrivalent
  172, WC-rBS
  173, BivWC
  174, live attenuated
  175 Rabies vaccine from human diploid cell cultureRabies - IM Diploid cell culture
  176 rabies vaccine from Chicken fibroblast cultureRabies - IM fibroblast culture
  177 conjugate vaccine, 10 valentPCV10
  178 bivalent oral polio vaccine (types 1 and 3)OPV bivalent
  179 monovalent oral polio vaccine, unspecified formulationOPV ,monovalent, unspecified
  180 immune globulin
  181 immune globulin
  182 Polio Vaccine, Unspecified formulationOPV, Unspecified
  183 fever vaccine alternative formulationYellow fever vaccine - alt
  184 fever vaccine, unspecified formulationYellow fever, unspecified formulation
  185, quadrivalent, recombinant, injectable influenza vaccine, preservative freeinfluenza, recombinant, quadrivalent,injectable, preservative free
  186, injectable, Madin Darby Canine Kidney, quadrivalent with preservativeInfluenza, injectable, MDCK, quadrivalent, preservative
  187 vaccine recombinantzoster recombinant
  188 vaccine, unspecified formulationzoster, unspecified formulation
  189 B vaccine (recombinant), CpG adjuvantedHepB-CpG
  190 conjugate vaccine (non-US)Typhoid conjugate vaccine (TCV)
  191 A polysaccharide vaccine (non-US)meningococcal A polysaccharide (non-US)
  192 AC polysaccharide vaccine (non-US)meningococcal AC polysaccharide (non-US)
  193 A and hepatitis B vaccine, pediatric/adolescent (non-US)Hep A-Hep B, pediatric/adolescent
  194, Southern Hemisphere, unspecified formulationInfluenza, Southern Hemisphere
  195, Tetanus, Poliomyelitis adsorbedDT, IPV adsorbed
  196 and diphtheria toxoids, adsorbed, preservative free, for adult use, Lf unspecifiedTd, adsorbed, preservative free, adult use, Lf unspecified
  197, high-dose seasonal, quadrivalent, .7mL dose, preservative freeinfluenza, high-dose, quadrivalent
  200, seasonal, Southern Hemisphere, quadrivalent, pediatric 0.25mL dose, preservative freeinfluenza, Southern Hemisphere, pediatric, preservative free
  201, seasonal, Southern Hemisphere, quadrivalent, 0.5mL dose, no preservativeinfluenza, Southern Hemisphere, preservative free
  202, seasonal, Southern Hemisphere, quadrivalent, 0.5mL dose, with preservativeinfluenza, Southern Hemisphere, quadrivalent, with preservative
  198, pertussis, tetanus, hepatitis B, Haemophilus Influenza Type b, (Pentavalent)DTP-hepB-Hib Pentavalent Non-US
  203 polysaccharide (groups A, C, Y, W-135) tetanus toxoid conjugate vaccine .5mL dose, preservative freemeningococcal polysaccharide (groups A, C, Y, W-135) TT conjugate
  205, seasonal vaccine, quadrivalent, adjuvanted, .5mL dose, preservative freeInfluenza vaccine, quadrivalent, adjuvanted
  206 monkeypox vaccine, live attenuated, preservative free (National Stockpile)Smallpox monkeypox vaccine (National Stockpile)
  207 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 100 mcg/0.5mL doseCOVID-19, mRNA, LNP-S, PF, 100 mcg/0.5 mL dose
  208 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 30 mcg/0.3mL doseCOVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose
  213 (COVID-19) vaccine, UNSPECIFIED
  210 (COVID-19) vaccine, vector non-replicating, recombinant spike protein-ChAdOx1, preservative free, 0.5 mLCOVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL
  212 (COVID-19) vaccine, vector non-replicating, recombinant spike protein-Ad26, preservative free, 0.5 mlCOVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL
  204 Zaire vaccine, live, recombinant, 1mL dose
  214, unspecified
  211 (COVID-19) vaccine, Subunit, recombinant spike protein-nanoparticle+Matrix-M1 Adjuvant, preservative free, 0.5mL per doseCOVID-19 vaccine, Subunit, rS-nanoparticle+Matrix-M1 Adjuvant, PF, 0.5 mL
  DTPurn:oid: Antigen
  ENGPurn:oid: B
  FVXJNRurn:oid: Junior
  GNHEPurn:oid: B
  GNHPAurn:oid: A
  GNJENurn:oid: Encephalitis
  GNMENurn:oid: C
  HATWNJurn:oid: Junior
  HAVAQurn:oid: Paed/Adol
  HAVJurn:oid: Junior
  HBVPurn:oid: II
  IFHXurn:oid: Hexa
  IFPAurn:oid: Penta
  MENVAXurn:oid: ACWY
  MMRCSLurn:oid: II
  PRVNRurn:oid: 7
  PRVTHurn:oid: 13
  VGRJNRurn:oid: Junior


See the full registry of value sets defined as part of FHIR.

Explanation of the columns that may appear on this page:

LvlA few code lists that FHIR defines are hierarchical - each code is assigned a level. For value sets, levels are mostly used to organize codes for user convenience, but may follow code system hierarchy - see Code System for further information
SourceThe source of the definition of the code (when the value set draws in codes defined elsewhere)
CodeThe code (used as the code in the resource instance). If the code is in italics, this indicates that the code is not selectable ('Abstract')
DisplayThe display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application
DefinitionAn explanation of the meaning of the concept
CommentsAdditional notes about how to use the code